Quest Partners LLC Portfolio Holdings

Quest Partners LLC

  • $1.53 Trillion
  • Q3 2025

Quest Partners LLC has filed its 13F form on November 03, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.53 Trillion distributed in 2237 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Barclays with a value of $39B, Ishares Barclays 3 7 Yr Treas with a value of $6.49B, Schwab Intermediate Term Us Tr with a value of $6.49B, Spdr Ser Tr Spdr Portfolio Int with a value of $6.49B, and Vanguard Intermediate Term Tre with a value of $6.49B.

Examining the 13F form we can see an increase of $512B in the current position value, from $1.02T to 1.53T.

Quest Partners LLC is based out at New York, NY

Below you can find more details about Quest Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.53 Trillion
Financial Services: $328 Billion
Industrials: $229 Billion
Technology: $160 Billion
Consumer Cyclical: $149 Billion
Healthcare: $123 Billion
Real Estate: $121 Billion
Utilities: $72 Billion
ETFs: $71.8 Billion
Other: $197 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$487M
$112 Million 0.01% of portfolio
9,859
Q3 2025 Reduced 57.41%
$125M
$138 Million 0.01% of portfolio
10,113
Q3 2025 Added 18,287.27%
$4.88B
$187 Million 0.01% of portfolio
2,209
Q3 2025 Added 1,612.4%
$4.84B
$92.7 Million 0.01% of portfolio
1,114
Q3 2025 Added 4.5%
$550M
$218 Million 0.01% of portfolio
9,028
Q3 2025 Reduced 29.8%
$6.36B
$135 Million 0.01% of portfolio
1,017
Q3 2025 Reduced 7.55%
$614M
$98.7 Million 0.01% of portfolio
3,490
Q1 2025 New
$3.53B
$77.6 Million 0.01% of portfolio
537
Q3 2025 Reduced 92.18%
$431M
$87.6 Million 0.01% of portfolio
2,167
Q3 2025 Reduced 77.07%
$838M
$223 Million 0.01% of portfolio
32,008
Q3 2025 Reduced 2.25%
$1.56B
$221 Million 0.01% of portfolio
41,484
Q2 2025 Added 0.41%
$401M
$130 Million 0.01% of portfolio
13,258
Q3 2025 New
$8.03B
$151 Million 0.01% of portfolio
788
Q3 2025 Reduced 53.18%
Monopar Therapeutics Inc
-
$158 Million 0.01% of portfolio
-
Q3 2025 Added 8.46%
$561M
$138 Million 0.01% of portfolio
7,707
Q3 2025 Reduced 12.84%
$671M
$202 Million 0.01% of portfolio
27,251
Q1 2025 Reduced 71.2%
$3.63B
$182 Million 0.01% of portfolio
7,151
Q3 2025 Added 142.57%
$19.8B
$85.5 Million 0.01% of portfolio
531
Q3 2025 Added 1,080.0%
$669M
$114 Million 0.01% of portfolio
1,019
Q3 2025 Added 1.49%
$2.16B
$130 Million 0.01% of portfolio
10,396
Q3 2025 New
$1.38B
$83.8 Million 0.01% of portfolio
14,675
Q2 2025 Added 20,281.94%
$319M
$176 Million 0.01% of portfolio
17,087
Q3 2025 Added 131.53%
$168B
$126 Million 0.01% of portfolio
1,663
Q3 2025 Reduced 45.44%
$13.2B
$224 Million 0.01% of portfolio
986
Q3 2025 Reduced 10.53%
$131M
$93.7 Million 0.01% of portfolio
4,324
Q3 2025 Added 483.54%
$545M
$225 Million 0.01% of portfolio
25,912
Q3 2025 Added 424.96%
$603M
$117 Million 0.01% of portfolio
12,636
Q3 2025 Reduced 72.69%
$485M
$107 Million 0.01% of portfolio
8,755
Q3 2025 Reduced 50.94%
$15.2B
$165 Million 0.01% of portfolio
2,224
Q3 2025 Reduced 53.88%
Nuveen Churchill Direct Lend
-
$135 Million 0.01% of portfolio
-
Q3 2025 New
$565M
$76.9 Million 0.01% of portfolio
1,453
Q3 2025 Reduced 87.66%
$39.8B
$117 Million 0.01% of portfolio
2,477
Q3 2025 Reduced 18.84%
$1.06B
$218 Million 0.01% of portfolio
12,420
Q3 2025 Added 978.13%
$288M
$113 Million 0.01% of portfolio
1,844
Q3 2025 New
$14.8B
$206 Million 0.01% of portfolio
1,460
Q3 2025 New
$2.76B
$177 Million 0.01% of portfolio
7,077
Q3 2025 Added 3.27%
$31.5B
$115 Million 0.01% of portfolio
1,582
Q3 2025 Reduced 85.18%
Onity Group Inc
-
$77.2 Million 0.01% of portfolio
-
Q3 2025 New
$274M
$132 Million 0.01% of portfolio
11,042
Q3 2025 Reduced 39.19%
$1.08B
$92.2 Million 0.01% of portfolio
8,135
Q3 2025 Reduced 27.53%
$5.17B
$99 Million 0.01% of portfolio
3,567
Q3 2025 Reduced 47.05%
$593B
$221 Million 0.01% of portfolio
786
Q3 2025 Added 882.5%
$1.92B
$99 Million 0.01% of portfolio
9,273
Q3 2025 Reduced 48.64%
$518M
$186 Million 0.01% of portfolio
15,500
Q3 2025 Reduced 23.1%
Oruka Therapeutics Inc
-
$207 Million 0.01% of portfolio
-
Q3 2025 Reduced 33.01%
$2.46B
$150 Million 0.01% of portfolio
7,947
Q3 2025 New
$557M
$116 Million 0.01% of portfolio
2,871
Q3 2025 Added 9.04%
$342B
$77.5 Million 0.01% of portfolio
425
Q3 2025 Added 15.8%
Palladyne Ai Corp
-
$167 Million 0.01% of portfolio
-
Q3 2025 Added 67.14%

Summary

  • Portfolio
  • No. of Stocks 2,237
  • Current Value $1.53 Trillion
  • Prior Value $1.02 Trillion
  • Filing
  • Period Q3 2025
  • Filing Date November 03, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 309 stocks
  • Additional Purchases 1,061 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 736 stocks
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email